AI Summary

Medicaid's spending on autism therapy has seen a significant increase, with the program's expenditure on the therapy quintupling since 2021. This rapid growth in spending has raised concerns about the potential for overprescribing and fraud within the program. The sharp increase in Medicaid's spending on autism therapy far exceeds the growth in diagnoses, suggesting that other factors may be contributing to the surge. The implications of this trend are unclear, but it highlights the need for increased oversight and scrutiny of Medicaid's spending on autism therapy.

AI summaries can be wrong sometimes—always verify important details using the source article.